PIII - P3 Health gets Nasdaq notice for delisting plans appeal
- P3 Health Partners ( NASDAQ: PIII ) said that Nasdaq has started a process which could result in the delisting of the company’s securities from the exchange.
- The company intends to appeal the Staff Determination before a Nasdaq Hearing Panel and seek a further stay of any suspension or delisting action pending the hearing process, P3 said in an Oct. 4 press release.
- P3 noted that the request for a hearing must be made by Oct. 5.
- The Staff Determination was issued because the company has not filed its annual report on Form 10-K for the fiscal year ended Dec. 31, 2021 or its quarterly reports on Form 10-Q for March 31, and June 30.
For further details see:
P3 Health gets Nasdaq notice for delisting, plans appeal